Additionally, knockdown of PXN-AS1 attenuated BCR::ABL1-independent Imatinib resistance in CML cells via PXN-AS1/miR-635/GS/Gln/mTOR signaling pathway. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.